Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Donate to our blog

Your support will help Science & Enterprise continue to provide science news for business people and business news for scientists.

Grid Computing Harnessed for Childhood Cancer Research

An international consortium is seeking crowdsourced computing power to screen drug candidates for treating a number of cancers affecting children. . . . → Read More: Grid Computing Harnessed for Childhood Cancer Research

Precision Health Tech Network Expands, Invests $400M

Digital Life Alliance, a consortium of enterprises applying advanced technologies to health and medicine that plans to offer personalized solutions, is expanding to 7 members, as well as iCarbonX, the company that founded the network. . . . → Read More: Precision Health Tech Network Expands, Invests $400M

Alliance Plans Adaptive Clinical Trials for Brain Cancer

(DARPA.gov)

12 November 2015. A global collaboration plans a series of clinical trials that address precise molecular targets testing treatments for glioblastoma multiforme, an aggressive brain cancer. The alliance combines medical teams, researchers, and patient advocates to employ adaptive clinical trials, a type of clinical study that enables investigators to adjust research tactics as . . . → Read More: Alliance Plans Adaptive Clinical Trials for Brain Cancer

Patent Awarded for Early, Pre-Symptom Cancer Tests

Stefan Bossmann, left, and Deryl Troyer (Kansas State University)

16 June 2015. Three researchers at Kansas State University in Manhattan received a patent for an early-stage test that the inventors say can diagnose some solid tumor cancers well before symptoms develop. Kansas State chemistry professor Stefan Bossmann and anatomy-physiology professor Deryl Troyer, with postdoctoral . . . → Read More: Patent Awarded for Early, Pre-Symptom Cancer Tests

Trial Underway Testing Immunotherapy for Gout

Microscopic image of needle-like gout crystals (Bobjgalindo, Wikimedia Commons)

10 June 2015. An early-stage clinical trial is recruiting patients to test the safety of a treatment for severe gout that harnesses the immune system, but still avoids unwanted immune responses. The trial is conducted by the biotechnology company Selecta Biosciences at two sites in . . . → Read More: Trial Underway Testing Immunotherapy for Gout

Early Trial Underway Testing Brain Cancer Drug

(Research.gov)

24 December 2014. Kinex Pharmaceuticals, a developer of cancer therapies, began an early-stage clinical trial of an experimental treatment for tumors of support cells in the brain. The Buffalo, New York biotechnology company says the first patient received the drug code-named KX2-361 in the trial taking place at Roswell Park Cancer Institute, also . . . → Read More: Early Trial Underway Testing Brain Cancer Drug

University Starts Computer Science/Brain Research Consortium

3-D brain wiring illustration (NIH)

26 August 2014. Carnegie Mellon University in Pittsburgh organized an international consortium of researchers to apply computer science techniques to the study of brain research and behavior. The collaboration, known as BrainHub, includes researchers from nearby University of Pittsburgh, as well as Sun Yat-sen University in Guangzhou, China, Indian . . . → Read More: University Starts Computer Science/Brain Research Consortium

Laser Activation Tested as Potential Cancer Drug Delivery

Paras Prasad (University at Buffalo)

16 May 2014. Researchers from University at Buffalo in New York developed and tested in the lab a process harnessing lasers to activate drugs inside the body to kill cancer cells. Findings from the proof-of-concept study, led by Buffalo’s Paras Prasad with colleagues from universities in China and Korea, . . . → Read More: Laser Activation Tested as Potential Cancer Drug Delivery

Early Trial Tests Stem Cell Immunotherapy for Liver Cancer

(NLM.NIH.gov)

An early stage clinical trial by California Stem Cell Inc. in Irvine tested a therapy harnessing the body’s immune system to treat a common form of liver cancer. The trial, conducted with eight patients in Shanghai, China, showed the treatments were safe for patients with hepatocellular carcinoma and did not cause complications, according . . . → Read More: Early Trial Tests Stem Cell Immunotherapy for Liver Cancer

Surgical Masks Shown to Cut Flu Transmission

Influenza ultrastructure illustration (Dan Higgins, CDC)

Public health researchers at University of Maryland, with colleagues at Harvard, Boston University, and University of Hong Kong identified the main ways flu virus spreads through populations and specifically recommend flu sufferers wear surgical masks to stop the virus. The team led by Maryland and Harvard professor Donald . . . → Read More: Surgical Masks Shown to Cut Flu Transmission